Announcements
- 2025.06.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
- 2025.05.23 VOLUNTARY ANNOUNCEMENTTHE FOLLOW-UP RESULTS OF LUX-VALVE PLUS TRINITY STUDYAND JENSCLIP CLINICAL STUDY PRESENTED AT EUROPCR 2025,SHOWING GOOD SAFETY AND PERFORMANCE
- 2025.05.22 POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING HELD ON THURSDAY, MAY 22, 2025
- 2025.05.08 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
- 2025.04.22 NOTICE OF 2024 ANNUAL GENERAL MEETING
- 2025.04.22 PROXY FORM FOR THE 2024 ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, MAY 22, 2025
- 2025.04.22 (1) 2024 REPORT OF THE BOARD OF DIRECTORS (2) 2024 REPORT OF THE BOARD OF SUPERVISORS (3) 2024 AUDITED FINANCIAL STATEMENTS (4) 2024 ANNUAL REPORT (5) 2024 PROFIT DISTRIBUTION PLAN (6) RE-APPOINTMENT OF AUDITOR (7) REMUNERATION OF DIRECTORS (8) REMUNERATION OF SUPERVISORS (9) PROPOSED CHANGE IN THE INTENDED USE OF NET PROCEEDS (10) PROPOSED GRANTING OF REPURCHASE MANDATE TO REPURCHASE H SHARES AND (11) NOTICE OF 2024 ANNUAL GENERAL MEETING
- 2025.04.22 2024 Annual Report
- 2025.04.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
- 2025.03.25 VOLUNTARY ANNOUNCEMENT KEN-VALVE OBTAINED REGISTRATION APPROVAL FROM NMPA AND ACTIVE PROGRESSION OF COMMERCIALIZATION
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
